Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris

This publication has 20 references indexed in Scilit:

• Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: Report of a case and review of this new therapy for severe autoimmune disease
  Journal of the American Academy of Dermatology, 1999
• Erythropoietin Addition to Granulocyte Colony-Stimulating Factor Abrogates Life-Threatening Neutropenia and Increases Peripheral-Blood Progenitor-Cell Mobilization After Epirubicin, Paclitaxel, and Cisplatin Combination Chemotherapy: Results of a Randomized Comparison
  Journal of Clinical Oncology, 1999
• Mucosal and Mucocutaneous (Generalized) Pemphigus Vulgaris Show Distinct Autoantibody Profiles
  Journal of Investigative Dermatology, 1997
• Targeted Disruption of the Pemphigus Vulgaris Antigen (Desmoglein 3) Gene in Mice Causes Loss of Keratinocyte Cell Adhesion with a Phenotype Similar to Pemphigus Vulgaris
  The Journal of cell biology, 1997
• Pemphigus Vulgaris Antigen (Desmoglein 3) Is Localized in the Lower Epidermis, the Site of Blister Formation in Patients
  Journal of Investigative Dermatology, 1996
• Pemphigus Sera Recognize Conformationally Sensitive Epitopes in the Amino-Terminal Region of Desmoglein-1
  Journal of Investigative Dermatology, 1995
• Demonstration of an Adhering-Junction Molecule (Plakoglobin) in the Autoantigens of Pemphigus Foliaceus and Pemphigus Vulgaris
  New England Journal of Medicine, 1989
• Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen.
  Journal of Clinical Investigation, 1988
• Azathioprine in the treatment of pemphigus vulgaris
  Journal of the American Academy of Dermatology, 1987
• Induction of Pemphigus in Neonatal Mice by Passive Transfer of IgG from Patients with the Disease
  New England Journal of Medicine, 1982